Published in Hepatitis Weekly, December 17th, 2001
"We investigated the role played by N-glycans in the immunogenicity of HCV E1 envelope glycoprotein, a naturally poor immunogen," research collaborators in Europe said in the December 2001 issue of Journal of Virology.
Generating plasmid-based constructs containing E1 protein mutants for which the N-linked glycosylation site had been changed, INSERM investigator A. Fournillier, in conjunction with others at Bio-Merieux,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.